| 000 | 01251 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513140715.0 | ||
| 264 | 0 | _c19980513 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a1087-0156 | ||
| 024 | 7 |
_a10.1038/nbt0398-243 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodgson, J | |
| 245 | 0 | 0 |
_aPharmacogenomics: will the regulators approve? _h[electronic resource] |
| 260 |
_bNature biotechnology _cMar 1998 |
||
| 300 |
_a243-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenetics, Population |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aLondon |
| 650 | 0 | 4 |
_aPharmacogenetics _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aUnited States Food and Drug Administration _xlegislation & jurisprudence |
| 700 | 1 | _aMarshall, A | |
| 773 | 0 |
_tNature biotechnology _gvol. 16 _gno. 3 _gp. 243-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt0398-243 _zAvailable from publisher's website |
| 999 |
_c9495632 _d9495632 |
||